Open access and well-planned digital enhancements improve article discoverability and reader engagement, according to data from Springer Health+. Read about our research collaboration with @IpsenGroup, Springer Health+ and Oxford PharmaGenesis here tinyurl.com/y5nz5f2x #ISMPPEU2021

Read Open Pharma’s poster (number 28) in collaboration with Future Science Group to find out how they increased the submission of ORCID iDs by proof stage to 73.5% of corresponding authors, an increase of 43.4% from baseline! Ashley ISMPP #ISMPPEU2021 p28ieu21.congressposter.com

Are YOU measuring publication effectiveness? We routinely measure reach, engagement and impact for journal articles and congress presentations. Will Gattrell of @IpsenGroup, Heather Lang and @TomRees_MedComm of Oxford PharmaGenesis #ISMPPEU2021 poster 30 ismppposterhub.org/ismppeu2021/30

Being able to tell the difference between trustworthy and untrustworthy sources is vital for people making decisions about their health, explains Trishna Bharadia BA(hons), MFPM(hon) at #ISMPPEU2021

David Sampson gives clarification of NEJM position on #plainlanguagesummaries - they have no plans to do them and feel that the sponsor/author should take the responsibility, with organizations such as ISMPP developing guidelines Open Pharma Oxford PharmaGenesis #ISMPPEU2021

Are pharmaceutical companies using preprints? Check out poster 43, developed with Takeda to find out! p43ieu21.congressposter.com #Preprints #ISMPPEU2021

Pharma are using preprints (sometimes), mainly for COVID-19-related research. Nice to see this analysis of medRxiv, which builds on our older analysis of bioRxiv #ISMPPEU2021 #rstats p43ieu21.congressposter.com healthsciencelive.com/UK/522594

In 2019, we found that two-thirds of pharma-funded research was published #OpenAccess. Check out poster 32 for more information on our automated approach to determine open access rates! #OpenPharma #Transparency #ISMPPEU2021 p32ieu21.congressposter.com

Communicating health information: understand audience, help them engage, make them ready to receive, give them CONTEXT, compelling storytelling – and ultimately WHY, WHO CARES and SO WHAT? Very like the fundamentals established for the O'Reilly Media Head First books #ISMPPEU2021

A new paper on comparison of the coverage and mentions captured by the two altmetric aggregators- Altmetric.com and PlumX. It compares a very large dataset. link.springer.com/article/10.100… Sumit Kumar Banshal Mousumi Karmakar

Awesome news: #ISMPP17AM posters are open access! Do get in touch to chat about our experiences with publications metrics (poster #43) Oxford PharmaGenesis ISMPP ismppposterhub.org/ismpp2021am/43

How do you measure reach, engagement and impact for journal articles and congress presentations? This #ISMPP17AM poster presents a semi-automated tool from Will Gattrell of @IpsenGroup, Heather Lang and @TomRees_MedComm View the poster at ismppposterhub.org/ismpp2021am/43

No regrets

My master plan: 1. Get hired at Microsoft 2. Fix the bug where Excel thinks everything is a date 3. Quit

We need to sit around the the virtual campfire and tell war stories about what can go wrong. People need to understand WHY we do things in the way we do. Chris Winchester of Oxford PharmaGenesis on why best practice in medcomms is not just a tickbox exercise. #ISMPPEurope2022

Active learning is great for medical writer training too! Distilling experience into realistic scenarios for colleagues to tackle helps with later on-the-job application, e.g. RECOGNIZING WHEN to apply a skill. 'Reading and nodding' adds minimal value, as it is not participative.